According to the latest report by IMARC Group, titled, “Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global anticoagulants market size reached a value of US$ 34.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting a CAGR of 10.2% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Market Overview:

Blood clots form when blood thickens, forming a semi-solid mass in any part of the body. This can lead to severe health issues, such as heart attack, stroke, pulmonary embolism, transient ischemic attacks, deep vein thrombosis (DVT), etc. Owing to this, doctors prescribe anticoagulant drugs to people who are at a high risk of blood clot formation. These drugs aid in thinning blood, reducing or preventing blood clotting, and prolonging the clotting period. They are generally available in capsule or tablet form, including rivaroxaban, warfarin, dabigatran, apixaban, etc.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/anticoagulants-market/requestsample

Anticoagulants Market Trends and Drivers:

The sudden outbreak of the COVID-19 pandemic is leading to an increasing number of individuals becoming afflicted by hypercoagulability, which is becoming one of the biggest causes of mortality across the globe. This is catalyzing the demand for anticoagulant drugs to treat this thrombotic condition in critically ill or hospitalized patients. Moreover, the rising incidences of risk factors, such as trauma, extended sitting, smoking, blood disorders, autoimmune diseases, etc., that can cause blood clotting in various body parts are also augmenting the global market. Additionally, the growing prevalence of the human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, chronic inflammation, etc., is further propelling the market growth. Besides this, the improving diagnosis rates and the escalating need for target therapeutics are expected to fuel the anticoagulants market over the forecasted period.

Anticoagulants Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• Alexion Pharmaceuticals Inc
• Aspen Holdings
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company Limited
• Reddy’s Laboratories Ltd
• GlaxoSmithKline plc
• Johnson & Johnson Private Limited
• Pfizer Inc.

The report has segmented the market based on drug class, route of administration, distribution channel and application.

Breakup by Drug Class:

• Novel Oral Anticoagulants (NOACs)
• Heparin and Low Molecular Weight Heparin (LMWH)
• Vitamin K Antagonist
• Others

Breakup by Route of Administration:

• Oral Anticoagulant
• Injectable Anticoagulant

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Others

Breakup by Application:

• Atrial Fibrillation and Heart Attack
• Stroke
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Others

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

Ask Customization and Browse full report with TOC & List of Figure:
 
https://www.imarcgroup.com/anticoagulants-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800